Craft

Jiangsu Nhwa Pharmaceutical

Stock Price

¥26.7

2024-10-29

Market Capitalization

¥27 B

2024-10-29

Revenue

¥5.8 B

FY, 2025

Jiangsu Nhwa Pharmaceutical Summary

Company Summary

Overview
Jiangsu Nhwa Pharmaceutical ( 江苏恩华药业) is a company engaged in the production and sales of CNS (central nervous system) drugs. It offers products for anesthesiology, psychiatry, and neurology areas. In addition, the company researches and develops a series of cardiovascular products.
Type
Public
Status
Active
Founded
1978
HQ
Xuzhou Shi, CN | view all locations
Website
http://www.nhwa-group.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Xuzhou Shi, Jiangsu Sheng HQ

    China

    69 Minzhu S Rd, Yunlong Qu

Jiangsu Nhwa Pharmaceutical Financials

Summary Financials

Revenue (Q1, 2026)
¥1.6B
Gross profit (Q1, 2026)
¥1.1B
Net income (Q1, 2026)
¥317.6M
Cash (Q1, 2026)
¥1.4B
EBIT (Q1, 2026)
¥336.2M
Enterprise value
$26.0B

Footer menu